Showing results (721-730 of 2,393) with videos related to
Sort By:
Pageof 240
Cancer Biotherapy & Radiopharmaceuticals|September 30, 2004
Comparative biodistribution of potential anti-glioblastoma conjugates [111In]DTPA-hEGF and [111In]Bz-DTPA-hEGF in normal miceVladimir Tolmachev, Anna Orlova, Qichun Wei, et al.Crystengcomm|June 27, 2017
4-Aminoquinaldine monohydrate polymorphism: Prediction and impurity aided discovery of a difficult to access stable formDoris E Braun, Herbert Oberacher, Kathrin Arnhard, et al.Carbohydrate Research|February 13, 2010
N,N-Diacetylsialyl chloride--a novel readily accessible sialyl donor in reactions with neutral and charged nucleophiles in the absence of a promoterAnna V Orlova, Anna M Shpirt, Nadezhda Y Kulikova, et al.Zhurnal Vysshei Nervnoi Deiatelnosti Imeni I P Pavlova|November 1, 1988
[Effect an ACTH analog on the processes of learning and memory in rats]V M Getsova, N V Orlova, A A Folomkina, et al.Voprosy Virusologii|July 1, 1988
[Acid-stable and acid-labile interferons inducible by the bovine infectious rhinotracheitis virus]T G Orlova, O N Shcheglovitova, A F Shuliak, et al.Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|May 16, 2009
[Impact of exogenous glycine on actinomycin D resistance of Staphylococcus aureus strain adapted to the antibiotic]V G Bulgakova, T I Orlova, V A Grushina, et al.Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|November 1, 1991
[Development of integrative vectors for Actinomycetes--producers of antibiotics]A E Grigor'ev, D B Zhukov, V A Orlova, et al.Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii|August 4, 2007
[The rate of human herpes virus type 6 and cytomegalovirus among HIV-infected and healthy women from Chelyabinsk and Moscow]M Iu Kalugina, O A Orlova, T N Rybalkina, et al.Voprosy Onkologii|December 17, 2008
[Autoantibodies to steroid-producing ovarian cells in cancer patients]L M Bershteĭn, T E Poroshina, D A Vasil'ev, et al.Nuclear Medicine and Biology|July 2, 2011
Influence of an aliphatic linker between DOTA and synthetic Z(HER2:342) Affibody molecule on targeting properties of the (111)In-labeled conjugateVladimir Tolmachev, Joachim Feldwisch, Malin Lindborg, et al.Pageof 240